Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SUPN
#1402
Supernus Pharmaceuticals, Inc.
54.730
0
+0.48%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+0.48%
Mudança mensal
+10.77%
Mudança em 6 meses
+1.35%
Mudança anual
+1.35%
Fechamento anterior
54.470
0
Open
54.730
0
Bid
Ask
Low
54.730
0
High
54.730
0
Volume
97
Mercados
Ações
Cuidados de saúde
SUPN
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
52.92 M
53.39 M
54.38 M
54.73 M
55.81 M
—
Valuation ratios
Enterprise value
1.04 B
1.35 B
1.94 B
1.44 B
1.95 B
7.88 B
Price to earnings ratio
10.66
29.76
36.03
1 386.5
27.39
-56.25
Price to sales ratio
2.6
2.73
3.46
2.53
3.06
12.4
Price to cash flow ratio
9.76
12.47
19.78
13.86
11.77
69.6
Price to book ratio
1.81
1.94
2.61
1.67
1.95
3.48
Enterprise value to EBITDA ratio
5.08
9.7
3.7
3.14
3.57
34.66
Profitability ratios
Return on assets %
0.08
0.03
0.04
0
0.05
0
Return on equity %
0.17
0.07
0.07
0
0.07
0
Return on invested capital %
56.82
21.61
12.96
0.78
22.24
11.91
Gross margin %
89.92
87.05
86.93
86.21
88.23
354.45
Operating margin %
33.38
14.84
6.91
0.87
12.34
19.1
EBITDA margin %
39.42
24.06
78.86
75.63
82.45
90.12
Net margin %
24.39
9.21
9.1
0.22
11.16
0.27
Liquidity ratios
Quick ratio
2.37
1.63
0.93
1.43
2.16
8.32
Current ratio
2.57
1.91
1.07
1.7
2.35
9.16
Inventory turnover
1.4
1.12
0.98
0.99
1.18
1.36
Asset turnover
0.39
0.36
0.39
0.41
0.5
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.22
0
0
—
—
Long term debt to total equity ratio
0.49
0.46
0
0
—
—
Per share metrics
Operating cash flow per share
2.58
2.34
1.89
2
3.07
1.28
EBIT per share
3.48
1.97
7.14
6.75
8.31
1.08
EBITDA per share
3.82
2.57
8.53
8.28
9.75
2.6
Total debt per share
—
—
—
—
—
—
Cash per share
7.87
6.25
7.48
4.59
1.24
8.56
Net current asset value per share
11.74
11.07
11.9
8.88
12.26
48.18
Tangible book value per share
5.64
-1.59
1.08
3.69
7.09
28.14
Working capital per share
7.18
5.27
0.75
3.66
7.04
26.97
Book value per share
13.87
15.01
14.37
16.6
18.51
74.43
Notícias
TD Cowen eleva preço-alvo da Supernus Pharmaceuticals com relançamento da Onapgo
TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch
Ações da Supernus Pharmaceuticals atingem máxima de 52 semanas a US$ 57,76
Supernus Pharmaceuticals stock hits 52-week high at $57.76
Cantor Fitzgerald reitera classificação acima da média para Supernus com ganhos de fornecimento
Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
Lucro da Supernus veio abaixo das projeções por $0,48; receita supera estimativas
Supernus earnings missed by $0.48, revenue topped estimates
Supernus enfrenta teste de lucros após choque de rentabilidade no 3º tri
Supernus faces earnings test after Q3 shock to profitability
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline